Teladoc Health (TDOC) Receivables - Net (2014 - 2026)

Teladoc Health has disclosed Receivables - Net across 13 years of filings, most recently posting $213.6 million for Q1 2026.

• Receivables - Net for Q1 2026 came in at $213.6 million, down 8.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $213.6 million (down 8.3% YoY), and the FY2025 annual result was $192.8 million, down 9.96% from the prior year.
• Receivables - Net came in at $213.6 million for Q1 2026 at Teladoc Health, up from $192.8 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $233.0 million in Q1 2025 to a low of $191.5 million in Q1 2022.
• The 5-year median for Receivables - Net is $213.6 million (2026), against an average of $211.7 million.
• Across the five-year window, Receivables - Net climbed 24.62% in 2022 and retreated 9.96% in 2025, its largest moves.
• Teladoc Health's Receivables - Net stood at $210.6 million in 2022, then advanced by 3.26% to $217.4 million in 2023, then dropped by 1.51% to $214.1 million in 2024, then declined by 9.96% to $192.8 million in 2025, then increased by 10.79% to $213.6 million in 2026.
• The last three Receivables - Net figures came in at $213.6 million (Q1 2026), $192.8 million (Q4 2025), and $210.8 million (Q3 2025), per Business Quant data.